Top

Published in:

01-06-2017 | Original Paper

A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass

Authors: Pietro Manuel Ferraro, Angelo Minucci, Aniello Primiano, Elisa De Paolis, Jacopo Gervasoni, Silvia Persichilli, Alessandro Naticchia, Ettore Capoluongo, Giovanni Gambaro

Published in: Urolithiasis | Issue 3/2017

Abstract

Mutations of the CYP24A1 gene, encoding for the enzyme 25(OH)D-24-hydroxylase, can cause hypercalcemia, hypercalciuria, nephrolithiasis and nephrocalcinosis. We report the case of a 22-year-old male patient with recurrent nephrolithiasis, nephrocalcinosis, hypercalcemia with low parathyroid hormone levels, hypercalciuria and low bone mass. Gene sequencing showed that the patient had compound heterozygous mutations including a novel genotype of the CYP24A1 gene. Genetic CYP24A1 testing and biochemical analyses were offered to other family members; the father was heterozygous for the same novel genotype and was also affected with recurrent nephrolithiasis.

Tebben PJ, Milliner DS, Horst RL et al (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97(3):E423–E427CrossRefPubMedPubMedCentral

Schlingmann KP, Kaufmann M, Weber S et al (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365(5):410–421CrossRefPubMed

Streeten EA, Zarbalian K, Damcott CM (2011) CYP24A1 mutations in idiopathic infantile hypercalcemia. N Engl J Med 365(18):1741–1743CrossRefPubMed

Dauber A, Nguyen TT, Sochett E et al (2012) Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab 97(2):E268–E274CrossRefPubMed

Castanet M, Mallet E, Kottler M-L (2013) Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations. J Pediatr 163(4):1208–1210CrossRefPubMed

Meusburger E, Mündlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K (2013) Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation. Clin Kidney J 6(2):211–215CrossRefPubMedPubMedCentral

Fencl F, Bláhová K, Schlingmann KP, Konrad M, Seeman T (2013) Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene. Eur J Pediatr 172(1):45–49CrossRefPubMed

Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman EJ (2013) Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol 190(2):552–557CrossRefPubMed

Nesterova G, Malicdan MC, Yasuda K et al (2013) 1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis. Clin J Am Soc Nephrol CJASN 8(4):649–657CrossRefPubMed

10.

Colussi G, Ganon L, Penco S et al (2014) Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc—Eur Ren Assoc 29(3):636–643

11.

Jacobs TP, Kaufman M, Jones G et al (2014) A lifetime of hypercalcemia and hypercalciuria, finally explained. J Clin Endocrinol Metab 99(3):708–712CrossRefPubMedPubMedCentral

12.

Wolf P, Müller-Sacherer T, Baumgartner-Parzer S et al (2014) A case of “late-onset” idiopathic infantile hypercalcemia secondary to mutations in the CYP24A1 gene. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 20(5):e91–e95

13.

Dowen FE, Sayers JA, Hynes AM, Sayer JA (2014) CYP24A1 mutation leading to nephrocalcinosis. Kidney Int 85(6):1475CrossRefPubMed

14.

Figueres M-L, Linglart A, Bienaime F et al (2015) Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. Am J Kidney Dis Off J Natl Kidney Found 65(1):122–126CrossRef

15.

Molin A, Baudoin R, Kaufmann M et al (2015) CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J Clin Endocrinol Metab 100(10):E1343–E1352CrossRefPubMed

16.

Cools M, Goemaere S, Baetens D et al (2015) Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: a cross-sectional study. Bone 81:89–96CrossRefPubMed

17.

Ketha H, Kumar R, Singh RJ (2016) LC-MS/MS for identifying patients with CYP24A1 mutations. Clin Chem 62(1):236–242CrossRefPubMed

18.

O’Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA (2016) Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int 1–15. doi:10.1007/s00198-016-3615-6

19.

Gigante M, Santangelo L, Diella S et al (2016) Mutational spectrum of CYP24A1 gene in a cohort of Italian patients with idiopathic infantile hypercalcemia. Nephron 133(3):193–204CrossRefPubMed

20.

Halbritter J, Baum M, Hynes AM et al (2015) Fourteen monogenic genes account for 15 % of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 26(3):543–551CrossRefPubMed

21.

St-Arnaud R, Arabian A, Travers R et al (2000) Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141(7):2658–2666CrossRefPubMed

Title: A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass
Authors: Pietro Manuel Ferraro
Angelo Minucci
Aniello Primiano
Elisa De Paolis
Jacopo Gervasoni
Silvia Persichilli
Alessandro Naticchia
Ettore Capoluongo
Giovanni Gambaro
Publication date: 01-06-2017
Publisher: Springer Berlin Heidelberg
Published in: Urolithiasis / Issue 3/2017
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-016-0923-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Do the urolithiasis scoring systems predict the success of percutaneous nephrolithotomy in cases with anatomical abnormalities?

Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment

Fluoroscopy versus ultrasonography guided mini-percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease

Comparison of escalating, constant, and reduction energy output in ESWL for renal stones: multi-arm prospective randomized study

The value of hypercalciuria in patients with osteopenia versus osteoporosis

Erratum to: A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass